T&D : Supplementary Materials for the Six Months Ended September 30, 2018

1. Business Highlights

   (1) Policy Amount in Force ···································································································P3 (2) New Policy Amount ·······································································································P3 (3) Annualized Premiums ·····································································································P4 (4) Surrender and Lapse Amount·····························································································P4 (5) Surrender and Lapse Rate ·································································································P5

2. Status of General Account Assets

   (1) Investment Performance···································································································P6 (2) Asset Composition ·········································································································P7 (3) Changes in the Amount of Assets by Categories ······································································P7 (4) Investment Income ·········································································································P8 (5) Investment Expenses·······································································································P8 [Reference] Breakdown of Gains/Losses from Derivatives, net·····················································P8

   (6) Net Investment Income and Average Daily Balance by Asset Categories ·········································P9 (7) Securities ····················································································································P9 (8) Securities by Contractual Maturity Dates············································································· P11 (9) Stock Holdings by Industry ····························································································· P12 (10) Loans······················································································································· P12 (11) Loans by Contractual Maturity Dates ················································································· P13 (12) Loans to Domestic Companies by Company Size ··································································· P13 (13) Loans by Collateral Type ······························································································· P13 (14) Loans by Industry ········································································································ P14 (15) Foreign Investments ····································································································· P15 (16) Valuation Gains (Losses) on Trading Securities ····································································· P16

   (17) Fair Value Information on Securities (Except Trading Securities)················································ P17 (18) Fair Value Information on Monetary Trusts·········································································· P20 (19) Fair Value Information on Land, etc.·················································································· P20 (20) Fair Value Information on Derivative Transactions································································· P21

3. Status of Separate Account Assets

   (1) Balance of Separate Account Assets ·················································································· P23 (2) Policy Amount in Force ································································································· P23

4. Breakdown of Core Profit and Ordinary Profit

(1) Breakdown of Core Profit······························································································· P24 [Reference] Positive Spread/Negative Spread ······································································ P25

(2) Breakdown of Ordinary Profit·························································································· P25

Fair Value Information on Financial Instruments ······································································ P29

Percentages are rounded to the nearest relevant percentage point. Therefore, the sums of each percentage do not always amount to 100%.

1. Policy Amount in Force

   (Number: Thousands, 100 Millions of yen, %)

   Category		As of March 31, 2017		As of September 30, 2017
   		Number	Amount	Number		Amount
   				Change from Previous FYE (%)	Change from Previous FYE (%)
   Individual insurance		1,809	365,380	1,827	101.0	364,457	99.7
   Individual term life insurance	1,204	347,724	1,196	99.4	347,174	99.8
   Individual annuities		167	12,875	167	99.7	12,752	99.0
   Subtotal		1,977	378,256	1,994	100.9	377,209	99.7
   Group insurance		-	68,192	-	-	65,671	96.3
   Group annuities		-	7,333	-	-	7,241	98.7

   Notes:

2. Policy amount in force for individual annuities is the sum of the funds to be held at the time annuity payments are to commence for an annuity for which annuity payments have not yet commenced and the amount of policy reserve for an annuity for which payments have commenced.

3. Policy amount in force for group annuities is equal to the amount of outstanding policy reserve.

4. Amount adding the total insured amount of "J-type product" and "T-type product", the Company's core products, along with term life insurance, and "Kaigo Relief", which was launched in October 2015 to subtotal of individual insurance and individual annuities is as follows. (Number of "J-type product", "T-type product", and "Kaigo Relief" is included in the above table, however amount of these products is not included in policy amount in force because these products do not cover death benefits.)

5. (Number: Thousands, 100 Millions of yen, %)

   Category		As of March 31, 2017		As of September 30, 2017
   		Number	Amount	Number		Amount
   				Change from Previous FYE (%)	Change from Previous FYE (%)
   Subtotal including "J-type product", "T-type product", and "Kaigo Relief"		1,977	409,922	1,994	100.9	412,518	100.6
   "J-type product", "T-type product", and "Kaigo Relief"	[156]	31,666	[176]	[112.8]	35,309	111.5

6. New Policy Amount

   (Number: Thousands, 100 Millions of yen, %)

   Category	Six Months Ended September 30, 2016
   	Number	Change (%)	Amount	Change (%)	New policies	Increase from conversion
   Individual insurance	99	105.6	18,686	103.9	18,734	(48)
   Individual term life insurance	54	100.2	18,428	104.3	18,478	(50)
   Individual annuities	2	128.4	212	118.2	212	-
   Subtotal	101	106.1	18,898	104.0	18,946	(48)
   Group insurance	-	-	35	112.1	35
   Group annuities	-	-	0	497.6	0

   (Number: Thousands, 100 Millions of yen, %)

   Six Months Ended September 30, 2017
   Number	Change (%)	Amount	Change (%)	New policies	Increase from conversion
   Individual insurance	93	94.2	14,919	79.8	14,955	(35)
   Individual term life insurance	47	87.8	14,773	80.2	14,810	(36)
   Individual annuities	2	90.2	161	75.9	161	-
   Subtotal	95	94.1	15,080	79.8	15,116	(35)
   Group insurance	-	-	9	26.7	9
   Group annuities	-	-	0	771.0	0

   Notes:

7. Unless stated otherwise, % changes are presented in comparison with the same period of the previous year.

8. The number of new policies includes increase from conversion.

9. The amount of new policies and increase from conversion for individual annuities are funds to be held at the time annuity payments are to commence for an annuity.

10. The new policy amount for group annuities is equal to the initial premium payment.

11. Amount adding the total insured amount of "J-type product", "T-type product", and "Kaigo Relief" to subtotal of individual insurance and individual annuities is as follows. (Number of "J-type product", "T-type product", and "Kaigo Relief" is included in the above table, however amount of these products is not included in new policy amount because these products do not cover death benefits.)

12. (Number: Thousands, 100 Millions of yen, %)‌

    Category		Six Months Ended September 30, 2016
    		Number	Change (%)	Amount	Change (%)	New policies	Increase from conversion
    Subtotal including "J-type product" and "T-type product"		101	106.1	23,145	104.0	23,193	(48)
    "J-type product" and "T-type product"	[21]	[123.8]	4,246	103.9	4,246	-

    (Number: Thousands, 100 Millions of yen, %)

    Category		Six Months Ended September 30, 2017
    		Number	Change (%)	Amount	Change (%)	New policies	Increase from conversion
    Subtotal including "J-type product", "T-type product", and "Kaigo Relief"		95	94.1	19,921	86.1	19,957	(35)
    "J-type product" and "T-type product" , and "Kaigo Relief"	[25]	[119.0]	4,840	114.0	4,840	-

13. Annualized Premiums

14. Policies in force (Millions of yen, %)

    Category		As of March 31, 2017		As of September 30, 2017
    		Amount	Change from Previous FYE (%)	Amount	Change from Previous FYE (%)
    Individual insurance		683,150	106.3	689,983	101.0
    Individual annuities		64,658	102.6	63,948	98.9
    Total		747,808	106.0	753,932	100.8
    Medical benefits, living benefits, and others	85,363	112.1	88,942	104.2

15. New policies (Millions of yen, %)

16. Category		Six Months Ended September 30, 2016		Six Months Ended September 30, 2017
    		Amount	Change (%)	Amount	Change (%)
    Individual insurance		40,721	102.8	33,260	81.7
    Individual annuities		864	118.9	640	74.1
    Total		41,586	103.1	33,900	81.5
    Medical benefits, living benefits, and others	6,960	105.5	6,754	97.0

    Notes:

17. The amount of annualized premium is the annual premium amount calculated by multiplying factors according to the premium payment method to a single premium payment amount (for lump-sum payment, the amount is the total premium divided by the insured period).

18. The amount of "Medical benefits, living benefits, and others" represents annualized premium related to medical benefits (hospitalization benefits, surgical benefits, and others), living benefits (specified illness benefits, nursing care benefits, and others), and waiver of premium benefits (disability cause is excluded but causes such as specific illness and nursing care are included).

19. New policies include net increase from conversions

20. Surrender and Lapse Amount

21. (Number: Thousands, 100 Millions of yen, %)

    Category	Six Months Ended September 30, 2016				Six Months Ended September 30, 2017
    	Number		Amount		Number		Amount
    	Change (%)	Change (%)	Change (%)	Change (%)
    Individual insurance	61	97.0	11,778	97.9	62	102.1	11,954	101.5
    Individual annuities	1	91.6	139	87.5	1	90.1	130	93.2
    Total	63	96.8	11,918	97.8	64	101.8	12,085	101.4

    Note: Amount adding the total insured amount of "J-type product", "T-type product", and "Kaigo Relief" to subtotal of individual insurance and individual annuities is as follows. (Number of "J-type product", "T-type product", and "Kaigo Relief" is included in the above table, however amount of these products is not included in surrender and lapse amount because these products do not cover death benefits.)

    (Number: Thousands, 100 Millions of yen, %)

    Category	Six Months Ended September 30, 2016				Six Months Ended September 30, 2017
    	Number		Amount		Number		Amount
    	Change (%)	Change (%)	Change (%)	Change (%)
    Subtotal including "J-type product", "T-type product", and "Kaigo Relief"	63	96.8	12,613	99.3	64	101.8	13,059	103.5